Events /// Investor News /// Investment Case /// Resources
Bayer is committed to providing sustainable solutions that address humanity’s most fundamental needs for essential healthcare and nutritious food. The Bayer Investor Relations Team is dedicated to creating transparency, fostering dialogue, and delivering value to our stakeholders.
Investor Resources
Investor News
Share Price / Index
September 17, 2026
Not intended for U.S. and UK Media
U.S. FDA approves finerenone for new indication in patients with chronic kidney disease associated with type 1 diabetes
September 09, 2026
Not intended for U.S. and UK Media
U.S. FDA grants accelerated approval to Bayer’s targeted therapy sevabertinib as a first-line treatment option for adults with HER2-mutant non-small cell lung cancer
September 09, 2026
Bayer and Neste close commercial agreement to jointly scale newgold® winter canola for biofuels production
Discover More
